title: [When cholesterol lowering drugs should not be too expensive. Statins are especially effective in secondary prevention].
authors.affiliation: Medizinischen Poliklinik, Charité, Medizin. Fakultät d. Humboldt-Universität zu Berlin. hans-peter.thomas@charite.de
authors.forename: H P
authors.initials: HP
authors.lastname: Thomas
authors.forename: U
authors.initials: U
authors.lastname: Kassner
authors.forename: E
authors.initials: E
authors.lastname: Steinhagen-Thiessen
mesh_terms: D000924:Anticholesteremic Agents / Q000191:economics* / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000191:economics*; D003362:Cost-Benefit Analysis; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics* / Q000627:therapeutic use; D012008:Recurrence
chemical_list: D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors